President Donald Trump is directing the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs.”Trump signed the executive order o
“These treatments are currently in the advanced stages of clinical trials to ensure that they’re both safe and effective for the American patients,” Trump said.
Trending
- AI Is Now Engineering Pathogenic Proteins That Could Threaten the Entire Human Race
- The Depopulation Medical Agenda Won’t Be Convenient — And That’s the Point
- Unlikely alliance targets GRAS loophole in America’s ultra-processed food crisis
- Echoes of the Remnant: A call to arms for the faithful in a time of crisis
- Report: Secret Service Used Decoy Aircraft to Transport Trump from Turkey Amid Iran Threat
- Former Pfizer Toxicologist’s Book Alleges COVID-19 Shots Were Sold Without Proper Safety Testing
- Pentagon Drafting Nuclear Strategy to Expand Tactical Weapons Options, NBC Reports
- Report Details Eight Facts About COVID-Period Excess Mortality
